Table 1. Allelic difference and its association with chronicity and clearance of HBV infection.
SNP ID | Minor Allele | HBV carriers(2n = 1000) | Non-HBV infectedsubjects (2n = 490) | HBV Clearancesubjects (2n = 518) | OR (95% CI)* | p* | OR (95% CI)† | p† |
rs3077 | T | 207 (20.7%) | 141 (28.8%) | 143 (27.6%) | 0.67 (0.51–0.88) | 0.0040 | 1.41 (1.09–1.82) | 0.0083 |
rs9277378 | A | 242 (24.2%) | 159 (32.5%) | 176 (34.0%) | 0.70 (0.54–0.91) | 0.0068 | 1.61 (1.26–2.05) | 0.00011 |
rs3128917 | T | 335 (33.5%) | 202 (41.2%) | 231 (44.6%) | 0.78 (0.62–1.00) | 0.054 | 1.54 (1.23–1.93) | 0.00017 |
All logistic regression analyses were adjusted for age and sex.
HBV carriers vs. non-HBV infected subjects.
Clearance subjects vs. HBV carriers.